NASDAQ: LFMD
Lifemd Inc Stock

$4.82-0.09 (-1.83%)
Updated Jun 16, 2026
LFMD Price
$4.82
Fair Value Price
N/A
Market Cap
$233.11M
52 Week Low
$2.56
52 Week High
$15.84
P/E
96.4x
P/B
15.5x
P/S
0.78x
PEG
4.12x
Dividend Yield
N/A
Revenue
$219.42M
Earnings
$5.21M
Gross Margin
87.8%
Operating Margin
2.84%
Profit Margin
1%
Debt to Equity
3.66
Operating Cash Flow
$6M
Beta
1.48
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

LFMD Overview

LifeMD, Inc. operates as a leading digital health company, specializing in direct-to-consumer telemedicine across the United States. The firm links individuals with licensed medical professionals to address a diverse spectrum of health concerns, including concierge services, men's sexual health, dermatological conditions, and more. Under its umbrella, LifeMD manages several specialized virtual care platforms: ShapiroMD is a telehealth brand focused on hair restoration, delivering virtual consultations, prescription medications, patented over-the-counter formulations, an FDA-cleared medical device, and custom-compounded topical treatments for both male and female hair loss. RexMD serves as a men's telehealth brand, providing virtual medical treatment from licensed providers for a wide array of male-specific health needs. LifeMD Primary Care offers a personalized, subscription-based virtual primary care solution, addressing routine, urgent, and chronic health management requirements. This mobile-centric platform integrates remote consultations, medication management, diagnostic services, and imaging referrals. Cleared is a telehealth service dedicated to offering personalized therapies for allergic, asthmatic, and immunological conditions. Nava MD stands as a skincare and tele-dermatology brand catering specifically to women, facilitating virtual access to dermatologists and other specialists for medical treatment. Additionally, the company provides PDFSimpli, a cloud-based software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents online. LifeMD distributes its offerings directly to individuals, via its own e-commerce channels, and through collaborations with external partners. Originally established in 1994 as Conversion Labs, Inc., the company rebranded to LifeMD, Inc. in February 2021 and is headquartered in New York City.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine LFMD's potential to beat the market

DSell
  • Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Health Information Service

Industry Rating
C
LFMD
Ranked
#40 of 45

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$39.90A
$26.60B
$64.14B
View Top Health Information Service Stocks

Be the first to know about important LFMD news, forecast changes, insider trades & much more!

LFMD News

Overview

Due Diligence Score

Industry Average (31)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how LFMD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

LFMD ($4.82) is trading above its intrinsic value of $0.66, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
LFMD is poor value based on its earnings relative to its share price (96.4x), compared to the US market average (13.25x)
P/E vs Market Valuation
LFMD is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more LFMD due diligence checks available for Premium users.

Valuation

LFMD price to earnings (PE)

For valuing profitable companies with steady earnings

Company
96.4x
Industry
14.5x
Market
13.25x
LFMD is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
LFMD is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

LFMD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
15.5x
Industry
3.09x
LFMD is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

LFMD price to earnings growth (PEG)

For valuing profitable companies with growth potential

LFMD is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

LFMD's financial health

Profit margin

Revenue
$50.2M
Net Income
-$8.9M
Profit Margin
-19.2%
LFMD's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
LFMD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$70.1M
Liabilities
$55.1M
Debt to equity
3.66
LFMD's short-term assets ($51.70M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LFMD's short-term assets ($51.70M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LFMD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
LFMD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$444.6k
Investing
-$2.1M
Financing
-$696.0k
LFMD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

LFMD vs Health Information Service Stocks

TickerZen RatingMarket Cap1d %P/EP/B
LFMDD$233.11M-1.83%96.40x15.50x
SPOKC$218.90M-1.13%16.90x1.55x
CARLD$287.34M-4.21%-4.89x3.11x
SYC$173.66M-2.81%-4.60x0.79x
HCATC$131.53M-3.26%-0.48x0.95x

Lifemd Stock FAQ

What is Lifemd's quote symbol?

(NASDAQ: LFMD) Lifemd trades on the NASDAQ under the ticker symbol LFMD. Lifemd stock quotes can also be displayed as NASDAQ: LFMD.

If you're new to stock investing, here's how to buy Lifemd stock.

What is the 52 week high and low for Lifemd (NASDAQ: LFMD)?

(NASDAQ: LFMD) Lifemd's 52-week high was $15.84, and its 52-week low was $2.56. It is currently -69.57% from its 52-week high and 88.28% from its 52-week low.

How much is Lifemd stock worth today?

(NASDAQ: LFMD) Lifemd currently has 48,362,510 outstanding shares. With Lifemd stock trading at $4.82 per share, the total value of Lifemd stock (market capitalization) is $233.11M.

Lifemd stock was originally listed at a price of $0.60 in Apr 1, 2013. If you had invested in Lifemd stock at $0.60, your return over the last 13 years would have been 703.33%, for an annualized return of 17.38% (not including any dividends or dividend reinvestments).

How much is Lifemd's stock price per share?

(NASDAQ: LFMD) Lifemd stock price per share is $4.82 today (as of Jun 16, 2026).

What is Lifemd's Market Cap?

(NASDAQ: LFMD) Lifemd's market cap is $233.11M, as of Jun 17, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Lifemd's market cap is calculated by multiplying LFMD's current stock price of $4.82 by LFMD's total outstanding shares of 48,362,510.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.